Kintai Therapeutics launches to tackle the interface between the gut, immune system, and brain

Tuesday, May 28, 2019 - 20:08 in Biology & Nature

The startup, founded by Flagship Pioneering, is developing small-molecule drugs aimed at the gut microbiome, gut immune cells, and enteric nervous system

Read the whole article on

More from

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net